Stock XOMA XOMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus XOMA Corporation

Equities

XOMA

US98419J2069

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
24.59 USD +1.40% Intraday chart for XOMA Corporation -6.15% +32.92%
Apr. 03 XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. CI
Mar. 08 XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on XOMA Corporation

Price target over the last 5 years

History of analyst recommendation changes

167c072cecd037e13477619b48.uU-YTpKoU5KBPtuiZ44B7SfGC4FpLiVvJh7z8Jl-F_4.9ArKP8rSJv2xa6OaAfxDvR-tWcw4bEZXHyuAms1KX8n3J9MX4cFi89Jngg~2e67972e63865326b34cacad2c5259ee

Analyst Recommendations on XOMA Corporation

HC Wainwright Adjusts Price Target on XOMA to $74 From $69, Maintains Buy Rating MT
XOMA : Wedbush Suspended Coverage on XOMA MT
XOMA : HC Wainwright Adjusts XOMA's Price Target to $69 from $56, Keeps Buy Rating MT
XOMA : Aegis Capital Adjusts XOMA Price Target to $56 From $60, Maintains Buy Rating MT
Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41 MT
XOMA : Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41 MT
XOMA : Aegis Capital Starts XOMA at Buy with $20.68 Price Target MT
XOMA : Wedbush Adjusts XOMA's Price Target to $41 From $36, Citing Iscalimab, Cetrelimab Projections; Outperform Rating Kept MT
XOMA : Wedbush Adjusts XOMA's Price Target to $36 From $29 on Vicineum Sales Forecast, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
24.59 USD
Average target price
74 USD
Spread / Average Target
+200.94%
High Price Target
74 USD
Spread / Highest target
+200.94%
Low Price Target
74 USD
Spread / Lowest Target
+200.94%

Consensus detail

Consensus revision (last 18 months)

Analysts covering XOMA Corporation

HC Wainwright
Wedbush
Aegis Capital

Ratings for XOMA Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. XOMA Stock
  4. Consensus XOMA Corporation